Yesterday the Food and Drug Administration (FDA) announced it has approved plasma from recovered COVID-19 patients to be used as a hospital-based treatment for the novel coronavirus under an emergency use authorization (EUA).The move was announced during an unscheduled press conference by President Donald Trump yesterday evening, just a day before the Republican National Convention begins.
Critics said Trump portrayed the EUA as a treatment breakthrough to boost support as the Nov 3 presidential election draws nearer."Based on the science and the data, the FDA has made the independent determination that the treatment is safe and very effective," Trump said.